HM Payson & Co’s Outset Medical OM Stock Holding History

HM Payson & Co’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1	Closed	-$1K	–	1120
2021 Q4	$1K	Buy	+1	New	+$740	﹤0.01%	1052

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

HM Payson & Co's OM Position: Q1 2022 in Review

HM Payson & Co sold out of Outset Medical (OM) in Q1 2022, closing a stake of 1 share — an estimated $1K sold.

HM Payson & Co first reported a position in OM in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 152 funds tracked by Wall St. Rank hold OM as of Q1 2022.

HM Payson & Co reported no remaining Outset Medical position as of Q1 2022 after selling out during the quarter.
HM Payson & Co sold 1 Outset Medical share in Q1 2022, an estimated $1K.
HM Payson & Co first reported a position in Outset Medical in Q4 2021 and held it in 1 quarter.
HM Payson & Co's Outset Medical position peaked at $1K in Q4 2021.
152 funds tracked by Wall St. Rank held Outset Medical as of Q1 2022.

Based on HM Payson & Co's 13F filing for Q1 2022, filed 12 May 2022.